Luca Pellegrinet

Luca Pellegrinet has a diverse work experience that spans over several years. Luca began their career as a Master Thesis Project at IEO European Institute of Oncology in 2006. After that, they joined ISREC - EPFL as a PhD student, where they worked from 2007 to 2011. During their time at ISREC - EPFL, they also served as a Postdoctoral Research Scientist for a brief period from July 2011 to December 2011. Luca then moved on to the University of Cambridge, where they worked as a Research Associate / Co-Investigator from March 2012 to September 2021. Following this, they joined Sanofi as a Senior Scientist / Team Leader in September 2021 and worked until June 2023. Currently, Luca is employed as an Associate Director at T-Therapeutics Ltd since June 2023.

Luca Pellegrinet's education history begins in 2001 when they enrolled at Università degli Studi di Padova for their Bachelor of Science degree in Biotechnology. Luca completed their B.Sc in 2004. Subsequently, in 2004, they continued their education at the same university and pursued a Master of Science degree in Medical Biotechnology, which they completed in 2007. Finally, from 2007 to 2011, Luca Pellegrinet attended EPFL (École polytechnique fédérale de Lausanne) where they earned their Ph.D. in Molecular Life Sciences.

In addition to their academic qualifications, Luca Pellegrinet obtained a certification as an Associate Fellow from the Higher Education Academy in September 2015.